| The probability of therapeutic drug monitoring (TDM)-guided tamoxifen dosing being cost-effective relative to standard tamoxifen is 92% at a willingness-to-pay (WTP) threshold of €20,000 per QALY gained. |
| This analysis suggests that TDM dominates standard tamoxifen care in terms of cost-effectiveness, gaining QALYs, life years and saving costs. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.